About LumiraDx
LumiraDx is a company based in Waltham (United States) founded in 2014 by Sumit Nagpal was acquired by Roche in January 2024.. LumiraDx has raised $703.91 million across 9 funding rounds from investors including Roche, Capital One and Gates Foundation. The company has 9 employees as of March 27, 2024. LumiraDx offers products and services including LumiraDx Instrument and LumiraDx Assays. LumiraDx operates in a competitive market with competitors including EKF, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
- Headquarter Waltham, United States
- Employees 9 as on 27 Mar, 2024
- Founders Sumit Nagpal
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lumiradx Healthcare Private Limited
- Date of Incorporation 07 Jul, 2021
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$115.02 K (USD)0as on Mar 31, 2022
-
Net Profit
$9.2 K (USD)0as on Mar 31, 2022
-
EBITDA
$17.76 K (USD)0as on Mar 31, 2022
-
Total Equity Funding
$703.91 M (USD)
in 9 rounds
-
Latest Funding Round
$14.2 M (USD), Grant
Dec 14, 2022
-
Investors
Roche
& 3 more
-
Employee Count
9
as on Mar 27, 2024
-
Acquired by
Roche
(Jan 02, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LumiraDx
LumiraDx offers a comprehensive portfolio of products and services, including LumiraDx Instrument and LumiraDx Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable system for point-of-care assays and health testing
Tests for detecting diseases from various sample types
Unlock access to complete
Unlock access to complete
Funding Insights of LumiraDx
LumiraDx has successfully raised a total of $703.91M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $14.2 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $14.2M
-
First Round
First Round
(17 Oct 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Grant - LumiraDx | Valuation |
investors |
|
| Apr, 2021 | Amount | Debt – Conventional - LumiraDx | Valuation |
investors |
|
| Dec, 2020 | Amount | Series D - LumiraDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LumiraDx
LumiraDx has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Roche, Capital One and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Provider of marketing services to biopharma sector
|
Founded Year | Domain | Location | |
|
Provider of loans, credit cards, and savings services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LumiraDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LumiraDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lumiradx Comparisons
Competitors of LumiraDx
LumiraDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, SpinChip, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
|
|
| domain | founded_year | HQ Location |
Medical diagnostics solutions are researched by the laboratory.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lumiradx
Frequently Asked Questions about LumiraDx
When was LumiraDx founded?
LumiraDx was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is LumiraDx located?
LumiraDx is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Who is the current CEO of LumiraDx?
Sumit Nagpal is the current CEO of LumiraDx. They have also founded this company.
Is LumiraDx a funded company?
LumiraDx is a funded company, having raised a total of $703.91M across 9 funding rounds to date. The company's 1st funding round was a Series D of $164M, raised on Oct 17, 2016.
How many employees does LumiraDx have?
As of Mar 27, 2024, the latest employee count at LumiraDx is 9.
What is the annual revenue of LumiraDx?
Annual revenue of LumiraDx is $115.02K as on Mar 31, 2022.
What does LumiraDx do?
LumiraDx a healthcare solutions care management company specializing in the comprehensive support of individuals with chronic disease. The flagship software solutions called Consult allow health and social care providers to view and manage patient records that are always joined up across all venues of care, from the doctors office to a patients home. The patient-facing version of this software Engage allows individuals to view, manage, and share their own history from across all venues of care. Their platform also connects with a growing list of home and point-of-care diagnostic devices and personal biometric devices that record real-time activity including continuous heart rate, surface temperature, posture, sleep, stress levels and integrates this data into individual longitudinal records.
Who are the top competitors of LumiraDx?
What products or services does LumiraDx offer?
LumiraDx offers LumiraDx Instrument and LumiraDx Assays.
Who are LumiraDx's investors?
LumiraDx has 4 investors. Key investors include Roche, Capital One, Gates Foundation, and bpcruk.